These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Results of prenatal management of fetuses with supraventricular tachycardia. A series of 66 cases]. Jouannic JM; Delahaye S; Le Bidois J; Fermont L; Villain E; Dommergues M; Dumez Y J Gynecol Obstet Biol Reprod (Paris); 2003 Jun; 32(4):338-44. PubMed ID: 12843882 [TBL] [Abstract][Full Text] [Related]
3. Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up. van der Heijden LB; Oudijk MA; Manten GT; ter Heide H; Pistorius L; Freund MW Ultrasound Obstet Gynecol; 2013 Sep; 42(3):285-93. PubMed ID: 23303470 [TBL] [Abstract][Full Text] [Related]
4. Flecainide in the intrauterine treatment of fetal supraventricular tachycardia. Krapp M; Baschat AA; Gembruch U; Geipel A; Germer U Ultrasound Obstet Gynecol; 2002 Feb; 19(2):158-64. PubMed ID: 11876808 [TBL] [Abstract][Full Text] [Related]
5. The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia. Frohn-Mulder IM; Stewart PA; Witsenburg M; Den Hollander NS; Wladimiroff JW; Hess J Prenat Diagn; 1995 Dec; 15(13):1297-302. PubMed ID: 8710768 [TBL] [Abstract][Full Text] [Related]
6. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study. Jaeggi ET; Carvalho JS; De Groot E; Api O; Clur SA; Rammeloo L; McCrindle BW; Ryan G; Manlhiot C; Blom NA Circulation; 2011 Oct; 124(16):1747-54. PubMed ID: 21931080 [TBL] [Abstract][Full Text] [Related]
7. Rapid control of foetal supraventricular tachycardia with digoxin and flecainide combination treatment. Uzun O; Babaoglu K; Sinha A; Massias S; Beattie B Cardiol Young; 2012 Aug; 22(4):372-80. PubMed ID: 22008551 [TBL] [Abstract][Full Text] [Related]
8. Fetal supraventricular tachycardia: a role for amiodarone as second-line therapy? Jouannic JM; Delahaye S; Fermont L; Le Bidois J; Villain E; Dumez Y; Dommergues M Prenat Diagn; 2003 Feb; 23(2):152-6. PubMed ID: 12575024 [TBL] [Abstract][Full Text] [Related]
9. Correlation of maternal flecainide concentrations and therapeutic effect in fetal supraventricular tachycardia. Vigneswaran TV; Callaghan N; Andrews RE; Miller O; Rosenthal E; Sharland GK; Simpson JM Heart Rhythm; 2014 Nov; 11(11):2047-53. PubMed ID: 25068572 [TBL] [Abstract][Full Text] [Related]
10. Flecainide as first-line treatment for fetal supraventricular tachycardia. Ekiz A; Kaya B; Bornaun H; Acar DK; Avci ME; Bestel A; Yildirim G J Matern Fetal Neonatal Med; 2018 Feb; 31(4):407-412. PubMed ID: 28114840 [TBL] [Abstract][Full Text] [Related]
11. [Fetal supraventricular tachyarrhythmias refractory to initial therapy]. Malvino E; Bruno MC; Gallo JP; Medrano JC; Ferrante D Medicina (B Aires); 2005; 65(2):138-42. PubMed ID: 16075808 [TBL] [Abstract][Full Text] [Related]
12. Flecainide versus digoxin for fetal supraventricular tachycardia: Comparison of two drug treatment protocols. Sridharan S; Sullivan I; Tomek V; Wolfenden J; Škovránek J; Yates R; Janoušek J; Dominguez TE; Marek J Heart Rhythm; 2016 Sep; 13(9):1913-9. PubMed ID: 27554948 [TBL] [Abstract][Full Text] [Related]
13. Sotalol as an effective adjunct therapy in the management of supraventricular tachycardia induced fetal hydrops fetalis. Refaat M; El Dick J; Sabra M; Bitar F; Tayeh C; Abutaqa M; Arabi M J Neonatal Perinatal Med; 2020; 13(2):267-273. PubMed ID: 31707376 [TBL] [Abstract][Full Text] [Related]
14. High-dose flecainide is the most effective treatment of fetal supraventricular tachycardia. Strizek B; Berg C; Gottschalk I; Herberg U; Geipel A; Gembruch U Heart Rhythm; 2016 Jun; 13(6):1283-8. PubMed ID: 26829115 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of sotalol as first-line therapy for fetal supraventricular tachyarrhythmias. Shah A; Moon-Grady A; Bhogal N; Collins KK; Tacy T; Brook M; Hornberger LK Am J Cardiol; 2012 Jun; 109(11):1614-8. PubMed ID: 22444730 [TBL] [Abstract][Full Text] [Related]
16. [European protocol for the management of fetal supraventricular tachycardia. European Association of Pediatric Cardiology]. Azancot-Benisty A; Areias JC; Oberhänsli I; Schmidt KG; Tulzer G; Viart P Arch Mal Coeur Vaiss; 1997 May; 90(5):735-43. PubMed ID: 9295960 [No Abstract] [Full Text] [Related]
17. Fetal supraventricular tachycardia complicated by hydrops fetalis: a role for direct fetal intramuscular therapy. Parilla BV; Strasburger JF; Socol ML Am J Perinatol; 1996 Nov; 13(8):483-6. PubMed ID: 8989479 [TBL] [Abstract][Full Text] [Related]
18. Fetal and maternal magnetocardiography during flecainide therapy for supraventricular tachycardia. Campbell JQ; Best TH; Eswaran H; Lowery CL Obstet Gynecol; 2006 Sep; 108(3 Pt 2):767-71. PubMed ID: 17018496 [TBL] [Abstract][Full Text] [Related]
19. Management of Fetal Supraventricular Tachycardia: Case Series from a Tertiary Perinatal Cardiac Center. Broom E; Thomas JT; Petersen S; Gooi A; Ward C; Gardener G; Kostner K; Lee-Tannock A; Kumar S Fetal Diagn Ther; 2021; 48(11-12):794-800. PubMed ID: 34753148 [TBL] [Abstract][Full Text] [Related]
20. Favourable outcome for hydrops or cardiac failure associated with fetal tachyarrhythmia: a 20-year review. Tunca Sahin G; Beattie RB; Uzun O Cardiol Young; 2022 Jul; 32(7):1077-1084. PubMed ID: 34551832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]